Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Supramolecular Salicylic Acid and Zinc for Malassezia Folliculitis
NCT06307223Phase 4Completed
- Sponsor
- Second Affiliated Hospital of Xi'an Jiaotong University
- Start
- Jun 2022
- Primary completion
- Sep 2023
- Modality
- Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of supramolecular salicylic acid in malassezia folliculitis, sponsored by Second Affiliated Hospital of Xi'an Jiaotong University. Started Jun 2022; status: completed.
02
Drugs
supramolecular salicylic acid
03
Conditions
malassezia folliculitis
Beyond the preview
Go deeper on NCT06307223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06307223.